an oncology-focused precision medicine company committed to the discovery and development of targeted cancer therapeutics for patient populations selected using molecular diagnostics.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CPOCX | 10.83 | 0.06 | +0.56% |
Morgan Stanley Insight L | |||
NSRSX | 48.70 | N/A | N/A |
Neuberger Berman Small Cap Growth R6 | |||
CLBAX | 34.34 | -0.06 | -0.17% |
American Funds American Balanced 529A | |||
HLIDX | 13.20 | -0.08 | -0.60% |
Harding Loevner Intl Dev Mkts Eq Inst | |||
OSPMX | 6.28 | -0.04 | -0.63% |
Invesco SteelPath MLP Income R6 |
A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.
Ticker / NAME | Correlation To IDYA | 1D Price Change % | ||
---|---|---|---|---|
IDYA | 100% | +0.26% | ||
GRI - IDYA | 54% Loosely correlated | -5.22% | ||
INAB - IDYA | 47% Loosely correlated | -3.07% | ||
SNDX - IDYA | 41% Loosely correlated | +4.81% | ||
TNGX - IDYA | 38% Loosely correlated | -0.50% | ||
PLRX - IDYA | 37% Loosely correlated | +4.79% | ||
More |